AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU
[ad_1] AstraZeneca PLC said Monday that its Imfinzi and Imjudo combinations have been recommended for marketing authorization in the European Union for advanced liver and lung cancer. The Anglo-Swedish pharma…